Morton Grove, IL, United States of America

Byron E Anderson

USPTO Granted Patents = 16 

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 219(Granted Patents)


Location History:

  • Liberty Lake, WA (US) (1993)
  • Norton Grove, IL (US) (1997)
  • Morton Grove, IL (US) (1993 - 2010)

Company Filing History:


Years Active: 1993-2010

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Byron E Anderson: Innovator in Peptide Research

Introduction

Byron E Anderson is a notable inventor based in Morton Grove, IL (US), recognized for his significant contributions to the field of peptide research. With a total of 16 patents to his name, Anderson has made strides in developing innovative methods and materials that have potential applications in medicine and biotechnology.

Latest Patents

Anderson's latest patents include groundbreaking work on peptides comprising aromatic D-amino acids. This invention discloses D-peptides and libraries of D-peptides that bind to proteins of interest, providing a foundation for further research in protein interactions. Another significant patent focuses on a method for inhibiting complement in mammals. This method involves administering a carrier with coupled dipeptides, which can enhance the survival of transplanted tissues and treat inflammatory responses. Additionally, he has developed a pharmaceutical composition that utilizes these dipeptides in a pharmaceutically acceptable vehicle.

Career Highlights

Throughout his career, Byron E Anderson has worked with prestigious institutions, including Northwestern University. His research has not only advanced the understanding of peptide interactions but has also opened new avenues for therapeutic applications.

Collaborations

Anderson has collaborated with notable colleagues such as Michael A Baumann and Lawrence A Potempa, contributing to a rich exchange of ideas and innovations in the field.

Conclusion

Byron E Anderson's work exemplifies the impact of innovative research in peptide technology. His patents and collaborations highlight his commitment to advancing scientific knowledge and improving medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…